TALENT study
Upendra Kaul
![Upendra Kaul]()
Upendra Kaul
Founder Director, Gauri Kaul foundation at Gauri Heart Centre Srinagar and Delhi
The study comparing an Indian coronary stent SUPRAFLEX with XIENCE the world market leader in a head to head comparison of all comers showed that SUPRAFLEX was equivalent (non inferior) to Xience. It was a major Late breaking trial at the TCT in San Diego CA, USA on 22nd Sept. the study was planned and co chaired by me and Dr Serruys from Rotterdam . The study will be published in LANCET very soon.
Consultant Interventional Cardiologist
6 年Great achievement !??????????
Chief Consultant Cardiologist, HOD, Former Chairman
6 年Great!
Senior Consultant Interventional and Structural Cardiologist Clinical Lead - Structural Heart Intervention@ Indraprastha Apollo Hospitals | TAVI/TAVR and MitraClip expert
6 年Congratulations Sir????
Medical devices , Endovascular, cardiology ,radiology and Neurointerventional
6 年Sir wonderful to see you on the TCT Dias.Hope you will be keeping the Indian scenario on and alive for the overseas organisations.Do let us know if anything worthwhile comes up. A thumbs up from your side will help a great deal.
Founder|Mentor|Entrepreneur|Consultant|Director|CEO
6 年Dr Upendra , after reducing the price of stents in India still coronary stent cost remains same. The ear we pull from it’s back or in front is the same thing... we need smart people in govt who should understand the functioning of Pvt hospitals way.. kudos